Cannabis law has never been more contradictory. In the U.S., federal and state governments often regulate identical products under completely different legal frameworks. Hemp and marijuana can produce the same intoxicating effects, yet lawmakers treat them as fundamentally different. Medical marijuana now occupies a unique place under federal law while adult use marijuana remains prohibited.
While most attention has focused on the recently concluded marijuana rescheduling hearing, an equally significant legal battle has unfolded in the D.C. Circuit over the final rescheduling order ("Final Order"). Petitioners, the Department of Justice, newly intervening parties, and amici participants have exchanged a series of briefs over the past month. Those filings may ultimately
Tomorrow morning at 10:00 a.m. PT, Harris Sliwoski attorney Jason Adelstone will join fellow cannabis industry professionals for a live webinar, The Cannabis Brief LIVE: Cannabis Rescheduling After the Hearing. The discussion will examine where federal cannabis rescheduling stands following the DEA administrative hearing process, what recent developments mean for the industry, and what cannabis
On April 28, 2026, Acting Attorney General Blanche (“AG”) issued a notice of hearing concerning the proposed rule to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (“CSA”). The notice replaced the hearing that began in December 2024 (“2024 Hearing”), which the AG terminated upon issuing the new notice. The
El 22 de mayo, los estados de Nebraska, Indiana y Luisiana presentaron un recurso de revisión ante el Tribunal de Apelación de los Estados Unidos para el Circuito del Distrito de Columbia («Circuito de DC») en el que impugnaban la resolución definitiva del fiscal general en funciones («FG») por la que se clasificaba la marihuana aprobada por la FDA y autorizada por los estados en la Lista III de la Ley de Sustancias Controladas («CSA»). El Circuito de DC
Oregon's 2026 legislative session began last week on February 2. The biennial "short session" will last but 35 days, and focus on budget shortfalls, transportation and housing—which is to say that cannabis is not a priority. That said, of the 300 or so introduced bills, there are four cannabis-related submissions. That’s where I come in.
El sector del cáñamo se enfrenta a su mayor transformación desde 2018. A partir del 13 de noviembre de 2025, el Congreso ha reformulado de manera radical la legislación que regula el cáñamo en Estados Unidos. En el proyecto de ley de financiación del Gobierno (a partir de la página 64) se incluye una disposición que redefinirá todo el sector del cáñamo, incluyendo un cambio fundamental en el tratamiento que reciben las semillas de marihuana en virtud de la legislación federal. Véase
Effective August 1, 2025, the New Mexico Environmental Department (NMED) issued emergency amendments to New Mexico's Hemp extraction, production, transportation, warehousing, and testing administrative code. These amendments were created to address concerns with the production and use of synthetic hemp cannabinoids found in finished products. The primary goal of NMED appears to be the protection
With so much discussion around the potential rescheduling of marijuana to Schedule III under the Controlled Substances Act (CSA), we must have an honest conversation about what such a move will—and more importantly, won't—accomplish. Let me be clear: marijuana absolutely needs to be removed from Schedule I. In fact, it should not be scheduled at
A lot of people want to save a buck during contract negotiations. These folks usually do not not use a lawyer for drafting term sheets or other initial matters. Sometimes, this can work out well. For bigger or more complicated deals, or for deals with a difficult opponent, this can be a bad idea. Let's
